Back to FATE
RENAISSANCE TECHNOLOGIES LLC → FATE
RENAISSANCE TECHNOLOGIES LLC FATE Position History
Fate Therapeutics, Inc. • Healthcare
Quarters held
13
Latest value
$8.1M
Q2 2026
Peak value
$18.2M
First seen
Q3 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2022 | $12M |
| Q4 2022 | $18.2M |
| Q1 2023 | $7.6M |
| Q2 2023 | $3.2M |
| Q3 2023 | $232K |
| Q2 2024 | $1.8M |
| Q3 2024 | $1.3M |
| Q4 2024 | $625K |
| Q2 2025 | $240K |
| Q3 2025 | $1.6M |
| Q4 2025 | $2.3M |
| Q1 2026 | $3.6M |
| Q2 2026 | $8.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $8.1M | 2.98M | — | — |
| Q1 2026 | $3.6M | 2.97M | — | — |
| Q4 2025 | $2.3M | 2.36M | — | — |
| Q3 2025 | $1.6M | 1.26M | — | — |
| Q2 2025 | $240K | 214.5K | — | — |
| Q4 2024 | $625K | 378.6K | — | — |
| Q3 2024 | $1.3M | 362.6K | — | — |
| Q2 2024 | $1.8M | 548.5K | — | — |
| Q3 2023 | $232K | 109.2K | — | — |
| Q2 2023 | $3.2M | 672.3K | — | — |
| Q1 2023 | $7.6M | 1.33M | — | — |
| Q4 2022 | $18.2M | 1.80M | — | — |
| Q3 2022 | $12M | 537.5K | — | — |